Anivance AI's hard organ-on-chip integrates a fully automated, dynamic air-liquid circulation system, designed for high-throughput imaging analysis. It’s a standout solution for respiratory and inhalable nanoparticle research, as well as other biomedical applications.

Our LaaS model, integrated with AI analytics, offers flexibility, affordability, and a complete solution for drug development. From discovery to clinical trials, we minimize human involvement and eliminate the need for animal testing, delivering reliable, data-driven results in collaboration with leading pharmaceutical companies.